Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus

Margo C. Honeyman, Vladimir Brusic, Leonard C. Harrison

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

T cells recognize peptide epitopes bound to major histocompatibility complex molecules. Human T-cell epitopes have diagnostic and therapeutic applications in autoimmune diseases. However, their accurate definition within an autoantigen by T-cell bioassay, usually proliferation, involves many costly peptides and a large amount of blood. We have therefore developed a strategy to predict T-cell epitopes and applied it to tyrosine phosphatase IA-2, an autoantigen in IDDM, and HLA-DR4(*0401). First, the binding of synthetic overlapping peptides encompassing IA-2 was measured directly to purified DR4. Secondly, a large amount of HLA-DR4 binding data were analysed by alignment using a genetic algorithm and were used to train an artificial neural network to predict the affinity of binding. This bioinformatic prediction method was then validated experimentally and used to predict DR4 binding peptides in IA-2. The binding set encompassed 85% of experimentally determined T-cell epitopes. Both the experimental and bioinformatic methods had high negative predictive values, 92% and 95%, indicating that this strategy of combining experimental results with computer modelling should lead to a significant reduction in the amount of blood and the number of peptides required to define T-cell epitopes in humans.

Original languageEnglish
Pages (from-to)401-404
Number of pages4
JournalAnnals of Medicine
Volume29
Issue number5
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

T-Lymphocyte Epitopes
Autoantigens
Type 1 Diabetes Mellitus
Peptides
HLA-DR4 Antigen
Computational Biology
Class 8 Receptor-Like Protein Tyrosine Phosphatases
T-Lymphocytes
Major Histocompatibility Complex
Biological Assay
Autoimmune Diseases
Epitopes

Keywords

  • Autoantigens
  • Insulin-dependent diabetes mellitus
  • T-cell epitopes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus. / Honeyman, Margo C.; Brusic, Vladimir; Harrison, Leonard C.

In: Annals of Medicine, Vol. 29, No. 5, 1997, p. 401-404.

Research output: Contribution to journalArticle

Honeyman, Margo C. ; Brusic, Vladimir ; Harrison, Leonard C. / Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus. In: Annals of Medicine. 1997 ; Vol. 29, No. 5. pp. 401-404.
@article{5ec7b666004c42d7bca1ce339aae40c4,
title = "Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus",
abstract = "T cells recognize peptide epitopes bound to major histocompatibility complex molecules. Human T-cell epitopes have diagnostic and therapeutic applications in autoimmune diseases. However, their accurate definition within an autoantigen by T-cell bioassay, usually proliferation, involves many costly peptides and a large amount of blood. We have therefore developed a strategy to predict T-cell epitopes and applied it to tyrosine phosphatase IA-2, an autoantigen in IDDM, and HLA-DR4(*0401). First, the binding of synthetic overlapping peptides encompassing IA-2 was measured directly to purified DR4. Secondly, a large amount of HLA-DR4 binding data were analysed by alignment using a genetic algorithm and were used to train an artificial neural network to predict the affinity of binding. This bioinformatic prediction method was then validated experimentally and used to predict DR4 binding peptides in IA-2. The binding set encompassed 85{\%} of experimentally determined T-cell epitopes. Both the experimental and bioinformatic methods had high negative predictive values, 92{\%} and 95{\%}, indicating that this strategy of combining experimental results with computer modelling should lead to a significant reduction in the amount of blood and the number of peptides required to define T-cell epitopes in humans.",
keywords = "Autoantigens, Insulin-dependent diabetes mellitus, T-cell epitopes",
author = "Honeyman, {Margo C.} and Vladimir Brusic and Harrison, {Leonard C.}",
year = "1997",
language = "English",
volume = "29",
pages = "401--404",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus

AU - Honeyman, Margo C.

AU - Brusic, Vladimir

AU - Harrison, Leonard C.

PY - 1997

Y1 - 1997

N2 - T cells recognize peptide epitopes bound to major histocompatibility complex molecules. Human T-cell epitopes have diagnostic and therapeutic applications in autoimmune diseases. However, their accurate definition within an autoantigen by T-cell bioassay, usually proliferation, involves many costly peptides and a large amount of blood. We have therefore developed a strategy to predict T-cell epitopes and applied it to tyrosine phosphatase IA-2, an autoantigen in IDDM, and HLA-DR4(*0401). First, the binding of synthetic overlapping peptides encompassing IA-2 was measured directly to purified DR4. Secondly, a large amount of HLA-DR4 binding data were analysed by alignment using a genetic algorithm and were used to train an artificial neural network to predict the affinity of binding. This bioinformatic prediction method was then validated experimentally and used to predict DR4 binding peptides in IA-2. The binding set encompassed 85% of experimentally determined T-cell epitopes. Both the experimental and bioinformatic methods had high negative predictive values, 92% and 95%, indicating that this strategy of combining experimental results with computer modelling should lead to a significant reduction in the amount of blood and the number of peptides required to define T-cell epitopes in humans.

AB - T cells recognize peptide epitopes bound to major histocompatibility complex molecules. Human T-cell epitopes have diagnostic and therapeutic applications in autoimmune diseases. However, their accurate definition within an autoantigen by T-cell bioassay, usually proliferation, involves many costly peptides and a large amount of blood. We have therefore developed a strategy to predict T-cell epitopes and applied it to tyrosine phosphatase IA-2, an autoantigen in IDDM, and HLA-DR4(*0401). First, the binding of synthetic overlapping peptides encompassing IA-2 was measured directly to purified DR4. Secondly, a large amount of HLA-DR4 binding data were analysed by alignment using a genetic algorithm and were used to train an artificial neural network to predict the affinity of binding. This bioinformatic prediction method was then validated experimentally and used to predict DR4 binding peptides in IA-2. The binding set encompassed 85% of experimentally determined T-cell epitopes. Both the experimental and bioinformatic methods had high negative predictive values, 92% and 95%, indicating that this strategy of combining experimental results with computer modelling should lead to a significant reduction in the amount of blood and the number of peptides required to define T-cell epitopes in humans.

KW - Autoantigens

KW - Insulin-dependent diabetes mellitus

KW - T-cell epitopes

UR - http://www.scopus.com/inward/record.url?scp=0030665681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030665681&partnerID=8YFLogxK

M3 - Article

C2 - 9453287

AN - SCOPUS:0030665681

VL - 29

SP - 401

EP - 404

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 5

ER -